Weekly epidemiological recordRelevé épidémiologique hebdomadaire 3 MAY 2024, 99th YEAR / 3 MAI 2024, 99e ANNÉE
No 18, 2024, 99, 203–224
The WHO position papers are concerned primarily with the use of vaccines in large-scale vaccination programmes.
The position papers are intended for use by... national public health officials and managers of immunization programmes.
This paper focuses on the second licensed dengue vaccine, TAK-003 (Qdenga, Takeda), along with WHO’s position for its use, and provides an update on the first licensed dengue vaccine, CYD-TDV.
more
BMC Public Health (2019) 19:1608
https://doi.org/10.1186/s12889-019-7853-3
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
A quick reference guide for health authorities and health-care workers
Revised 2015
Surveillance of antimicrobial resistance in Europe 2020 data: executive summary
Section I
Somatoform disorders
Child Psychiatry and Pediatrics
Chapter I.1
Session Outline
•General Principles
•Essentials of mental health care and clinical practice: Assessments
•Essentials of mental health care and clinical practice: Management
•Essentials of mental health care and clinical practice: Follow-up
•Reviews
Medicina (Kaunas) 2013;49(7):335-40
Standard Treatment Guideline
Facilitator's Guide
Refresher Training Module for Health Care Providers implementing the MISP
Inter-agency Working Group on Reproductive Health in Crises Training Partnership
Special issue: Mental Health Challenges in Lithuania
Nos. 1-2 '11